Sanofi considered moving headquarters abroad: report 
November 4th, 2012
PARIS | Sun Nov 4, 2012 11:04am EST PARIS (Reuters) – Sanofi’s management considered moving its headquarters abroad in the last few months but the plan was nixed by the drugmaker’s chairman, French weekly Le Journal du Dimanche reported on Sunday, citing sources close to the board. First mooted in July, when the Socialist government was preparing to introduce a 75 percent tax on top earnings, the plan envisaged moving the headquarters to London or the United States, or at least relocating Chief Executive Chris Viehbacher and his closest associates abroad
[Continue Reading...]
Insight: Crunching the numbers to boost odds against cancer
November 1st, 2012
A dispensing chemist prepares drugs for a chemotherapy treatment in a sterile room at Antoine-Lacassagne Cancer Centre in Nice October 18, 2012. Picture taken October 18, 2012
[Continue Reading...]
Bayer wins EU endorsement for Xarelto in lung embolism
October 19th, 2012
FRANKFURT | Fri Oct 19, 2012 8:30am EDT FRANKFURT (Reuters) – German drugmaker Bayer said its Xarelto blood-thinning pill was recommended for approval by the European drugs regulator for the treatment of dangerous blood clots of the lung, a condition known as pulmonary embolism. Bayer also won an endorsement from watchdog European Medicines Agency (EMA) for the pill’s use in preventing recurrent deep vein thrombosis – another form of blood clotting – Bayer said in a statement on Friday
[Continue Reading...]
Indoor tanning still common in Germany
October 15th, 2012
By Frederik Joelving NEW YORK | Mon Oct 15, 2012 4:55pm EDT NEW YORK (Reuters Health) – Four in ten Germans ages 14 to 45 say they have tried indoor tanning and one in seven are current users, according to a survey out today. Germany enacted legislation banning minors from tanning salons in 2009.
[Continue Reading...]
Biogen says new look at data bolsters oral MS drug
October 12th, 2012
Fri Oct 12, 2012 10:06am EDT (Reuters) – Biogen Idec Inc said on Friday that a closer look at data from two late-stage studies supported previous findings that its high-profile multiple sclerosis pill BG-12 significantly reduced relapses and progression of disability related to MS. The company said its confidence was bolstered by analyzing combined data from the two Phase 3 studies, called DEFINE and CONFIRM, and suggested that it could win U.S. marketing approval for BG-12 by the end of the year.
[Continue Reading...]
EU’s Almunia says Lundbeck, Servier decisions next year
October 8th, 2012
BRUSSELS | Mon Oct 8, 2012 12:34pm EDT BRUSSELS (Reuters) – EU regulators will decide next year whether to fine Danish drugmaker Lundbeck and French peer Servier for blocking the entry of cheaper generic medicines into the market, the EU’s antitrust chief said on Monday.
[Continue Reading...]
11,000 German schoolchildren probably laid low by strawberries
October 5th, 2012
BERLIN | Fri Oct 5, 2012 6:18pm EDT BERLIN (Reuters) – Germany’s biggest outbreak of food poisoning, in which more than 11,000 schoolchildren have been laid low by diarrhoea and vomiting, is “very likely” to have been caused by a batch of frozen strawberries, authorities said on Friday. Children in almost 500 schools and daycare centres across eastern Germany that received food from a subcontractor of the catering firm Sodexo have been affected, and at least 32 have been treated in hospital. The Robert Koch Institute, which advises the German Health Ministry on infectious diseases, said it had found a “strong and statistically significant link” between the outbreak and “consumption of products made from a batch of frozen strawberries”.
[Continue Reading...]
Lilly, Boehringer’s diabetes drug shows promise
October 2nd, 2012
Tue Oct 2, 2012 6:50am EDT (Reuters) – Eli Lilly and Co and German drugmaker Boehringer Ingelheim Pharmaceuticals Inc said data from two trials of their experimental diabetes treatment showed the drug reduced blood pressure in patients. Diabetes patients are prone to high blood pressure, which can raise the risk of other health complications.
[Continue Reading...]
Germany resumes ritual circumcisions after bitter dispute
October 1st, 2012
Clothes traditionally worn by Muslim boys before their circumcisions, are displayed in the window of the ”Kids Elegance” store in Berlin’s Neukoelln district, September 28, 2012. Credit: Reuters/Tobias Schwarz By Alexandra Hudson BERLIN | Mon Oct 1, 2012 11:10am EDT BERLIN (Reuters) – Shopkeeper Nevzat Cavan is rushing to meet orders for the white, fur-trimmed costumes worn by Muslim boys for their circumcision, relieved that Berlin’s city government has allowed the operations to resume
[Continue Reading...]
Thousands of German children suffer from vomit outbreak
September 28th, 2012
BERLIN | Fri Sep 28, 2012 2:25pm EDT BERLIN (Reuters) – More than 6,500 German children and teenagers have fallen ill with diarrhea and vomiting that health authorities say has likely been caused by a food-borne virus in meals delivered to schools and daycare centers. Regional health ministries and a top health research institute said youngsters from five of Germany’s 16 states had been affected by the acute gastroenteritis, with the first cases registered on Tuesday. So far, those affected had not suffered any complications
[Continue Reading...]
